Petrus Trust Company’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-92,000
Closed -$16.3M 338
2020
Q1
$16.3M Sell
92,000
-5,000
-5% -$941K 2.34% 16
2019
Q4
$18.5M Buy
97,000
+10,000
+11% +$1.8M 2.95% 11
2019
Q3
$14.6M Buy
87,000
+37,000
+74% +$6.03M 2.59% 14
2019
Q2
$8.37M Sell
50,000
-13,256
-21% -$1.84M 1.48% 23
2019
Q1
$9.26M Buy
63,256
+9,938
+19% +$1.44M 1.79% 22
2018
Q4
$7.13M Buy
53,318
+852
+2% +$140K 1.56% 25
2018
Q3
$9.99M Buy
52,466
+311
+0.6% +$57.1K 2.2% 14
2018
Q2
$8.7M Hold
52,155
1.85% 20
2018
Q1
$8.78M Hold
52,155
2.04% 17
2017
Q4
$8.53M Hold
52,155
2.11% 16
2017
Q3
$10.7M Buy
52,155
+6,900
+15% +$1.6M 2.53% 14
2017
Q2
$11M Buy
45,255
+3,055
+7% +$718K 2.56% 13
2017
Q1
$10.1M Sell
42,200
-5,100
-11% -$1.19M 2.27% 17
2016
Q4
$9.93M Buy
+47,300
New +$9.8M 2.44% 11

Other funds holding AGN

Petrus Trust Company's AGN Position: Q2 2020 in Review

Petrus Trust Company sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 92,000 shares — an estimated $16.3M sold.

Petrus Trust Company first reported a position in AGN in Q4 2016 and held it in 14 quarters. The position peaked at $18.5M in Q4 2019. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Petrus Trust Company reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Petrus Trust Company sold 92,000 Allergan plc shares in Q2 2020, an estimated $16.3M.
  • Petrus Trust Company first reported a position in Allergan plc in Q4 2016 and held it in 14 quarters.
  • Petrus Trust Company's Allergan plc position peaked at $18.5M in Q4 2019.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Petrus Trust Company's 13F filing for Q2 2020, filed 14 Aug 2020.